Cary Street Partners Financial LLC Has $15.66 Million Holdings in CME Group Inc. $CME

Cary Street Partners Financial LLC trimmed its stake in shares of CME Group Inc. (NASDAQ:CME) by 6.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,817 shares of the financial services provider’s stock after selling 3,952 shares during the period. Cary Street Partners Financial LLC’s holdings in CME Group were worth $15,660,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Norges Bank bought a new position in CME Group in the 2nd quarter worth approximately $1,571,447,000. GQG Partners LLC raised its position in shares of CME Group by 7,676.3% during the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock worth $584,975,000 after acquiring an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of CME Group by 370.5% during the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after acquiring an additional 2,089,935 shares during the period. Nuveen LLC bought a new position in CME Group in the first quarter valued at about $218,842,000. Finally, Alliancebernstein L.P. increased its position in CME Group by 185.5% in the first quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock worth $330,182,000 after purchasing an additional 808,740 shares during the period. 87.75% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Royal Bank Of Canada boosted their price target on shares of CME Group from $282.00 to $295.00 and gave the stock a “sector perform” rating in a research note on Friday. The Goldman Sachs Group reduced their price objective on shares of CME Group from $264.00 to $263.00 and set a “sell” rating on the stock in a research note on Thursday. Jefferies Financial Group lowered their target price on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a report on Friday, October 10th. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $289.18.

CME Group Trading Down 0.8%

Shares of NASDAQ CME opened at $270.87 on Friday. CME Group Inc. has a twelve month low of $224.62 and a twelve month high of $290.79. The stock has a market cap of $97.68 billion, a price-to-earnings ratio of 26.25, a P/E/G ratio of 4.22 and a beta of 0.28. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The company’s fifty day moving average is $271.57 and its 200-day moving average is $272.76.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the firm earned $2.68 EPS. CME Group’s quarterly revenue was down 3.0% compared to the same quarter last year. Equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s payout ratio is currently 48.45%.

Insider Activity at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of CME Group stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director directly owned 1,091 shares in the company, valued at $287,511.23. This represents a 47.82% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 2,147 shares of company stock valued at $562,079 in the last quarter. 0.30% of the stock is currently owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.